T1	Outcomes 1264 1320	5-year survival rate and the 5-year recurrence-free rate
T2	Outcomes 1536 1575	slightly longer recurrence-free period.
T3	Outcomes 1649 1708	levels of peripheral leukocytes and peripheral lymphocytes;
T4	Outcomes 1766 1800	Inhibition of bone marrow function
T5	Outcomes 1972 2007	certain level of immune performance
T6	Outcomes 2042 2064	improve survival rate.
